Want To Catch The Next Hot Investing Trend (Look Inside?)
While millennials are trying to get rich in crypto Ponzi schemes- there's something happening that Wall Street is TOTALLY ignoring. And it's about to affect every American Citizen over 55...
And It Could Spark An Economic Boom For Investors

ETX Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): £7,465.21
Insider Selling (Last 12 Months): GBX 0

e-therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at e-therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

e-therapeutics Share Price & Price History

Current Price: GBX 21.12
Price Change: Price Decrease of -0.783 (-3.58%)
As of 12/7/2022 05:05 PM ET

This chart shows the closing price history over time for ETX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Want To Catch The Next Hot Investing Trend (Look Inside?)
While millennials are trying to get rich in crypto Ponzi schemes- there's something happening that Wall Street is TOTALLY ignoring. And it's about to affect every American Citizen over 55...
And It Could Spark An Economic Boom For Investors

e-therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/4/2022Trevor Mervyn JonesInsiderBuy43,913GBX 17£7,465.21
10/26/2021Ali MortazaviInsiderBuy275,000GBX 37£101,750
1/4/2021Trevor Mervyn JonesInsiderBuy33,417GBX 16£5,346.72
7/14/2020Trevor Mervyn JonesInsiderBuy32,185GBX 17£5,471.45
1/2/2020Trevor Mervyn JonesInsiderBuy177,404GBX 3£5,322.12
See Full Table

SEC Filings (Institutional Ownership Changes) for e-therapeutics (LON:ETX)

e-therapeutics logo
e-Therapeutics plc engages in drug discovery research activities in the United Kingdom. Its computational platform provides in silico screens generate predictions on compounds and/or targets that can have a significant perturbative effect on the biology of interest, captured by its network models, as well as developing RNAi platform for highly specific gene silencing. The company was incorporated in 2001 and is based in London, the United Kingdom.
Read More on e-therapeutics

Today's Range

Now: GBX 21.12
Low: 21.12
High: 21.86

50 Day Range

MA: GBX 18.70
Low: 16.10
High: 23

52 Week Range

Now: GBX 21.12
Low: 14.50
High: 49.50

Volume

25,177 shs

Average Volume

288,232 shs

Market Capitalization

£122.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of e-therapeutics?

e-therapeutics' top insider investors include:
  1. Ali Mortazavi (Insider)
  2. Trevor Mervyn Jones (Insider)
Learn More about top insider investors at e-therapeutics.